We were involved in numerous projects where data were collected on patients with tumour diseases, we have prepared tens of new HTA dossiers, and are also taking part in independent scientific projects supported by patient and expert groups.

Our experience includes for example the following areas

• -  Multiple myeloma
• -  Thyroid cancer
• -  Colorectal cancer
• -  Renal cell carcinoma
• -  Chronic myeloid leukaemia
• -  Myelodysplastic syndrome
• -  Prostate cancer
• -  Acute myeloid leukaemia
• -  Non-Hodgkin lymphoma
• -  Breast cancer
• -  Ovarian cancer
• -  Sarcoma

Our most recent projects include

• -  Real-world economic aspects based on oncology registries
• -  Cost-effectiveness studies of direct and indirect costs of basic solid tumours
• -  Indirect data comparisons from real clinical practices and clinical studies
• -  Preparation of dossiers for highly innovative medicinal products
• -  Preparation of new pharmacoeconomic models from multiple sources
• -  Analysis of costs and benefits in radiotherapy
• -  Education of patient organizations in HTA, health economics
• -  Analysis of the market entry of new oncological molecules in the CR / SR
• -  Calculation of the prevalence and incidence of selected
     haematooncologic diagnoses